Journal List > Prog Med Phys > v.33(4) > 1516087470

Jin, An, Chie, Park, and Kim: Dosimetric Evaluation of Synthetic Computed Tomography Technique on Position Variation of Air Cavity in Magnetic Resonance-Guided Radiotherapy

Abstract

Purpose

This study seeks to compare the dosimetric parameters of the bulk electron density (ED) approach and synthetic computed tomography (CT) image in terms of position variation of the air cavity in magnetic resonance-guided radiotherapy (MRgRT) for patients with pancreatic cancer.

Methods

This study included nine patients that previously received MRgRT and their simulation CT and magnetic resonance (MR) images were collected. Air cavities were manually delineated on simulation CT and MR images in the treatment planning system for each patient. The synthetic CT images were generated using the deep learning model trained in a prior study. Two more plans with identical beam parameters were recalculated with ED maps that were either manually overridden by the cavities or derived from the synthetic CT. Dose calculation accuracy was explored in terms of dose-volume histogram parameters and gamma analysis.

Results

The D95% averages were 48.80 Gy, 48.50 Gy, and 48.23 Gy for the original, manually assigned, and synthetic CT-based dose distributions, respectively. The greatest deviation was observed for one patient, whose D95% to synthetic CT was 1.84 Gy higher than the original plan.

Conclusions

The variation of the air cavity position in the gastrointestinal area affects the treatment dose calculation. Synthetic CT-based ED modification would be a significant option for shortening the time-consuming process and improving MRgRT treatment accuracy.

Introduction

Magnetic resonance image-guided radiotherapy (MRgRT) systems are becoming more important in radiation oncology [1-4]. It provided real-time soft tissue imaging via an onboard magnetic resonance (MR) scanner, which has better soft tissue visualization than conventional computed tomography (CT) or cone-beam CT imaging [5,6]. The superior contrast of tissue allows for the daily management of interfraction anatomical variation, particularly in large areas like the abdomen [3]. These imaging characteristics allow online adaptive radiation therapy (ART) to account for ongoing patient anatomy changes throughout the treatment, resulting in more accurate tumor targeting [1].
One of the most significant barriers to online ART clinical practice is the cost of increased time for recontouring, reoptimization, and dose calculation. The process of updating the electron density (ED) map is especially important [2]. The ED map is assigned daily based on a deformable registration of simulation CT and daily MR images [7]. Although the deformable registration algorithm is conducted, it is challenging to accurately deform even the air pocket in the bowl, which can cause significant changes in the ED map. Therefore, in the ART process, the air cavities of simulation CT and daily MR are manually contoured and bulk-assigned water and air density, respectively.
Recently, a synthetic CT image generation which is the direct conversion of MR into CT images based on a deep learning technique has been suggested by significant researchers in the radiotherapy field [8-12]. This approach has the potential to improve the dose calculation accuracy than the previous synthetic CT approach which delineated volumes with a homogeneous ED, referred to as bulk density [13]. To date, there have been few studies that have compared the influence of the ED overridden with the synthetic CT to the manually assigned method, particularly for the air cavity variation.
In this study, we retrospectively assessed the dosimetric impacts of ED maps derived from manually assigned volume and synthetic CT images on the position variability of the air cavity in pancreatic cancer MRgRT.

Materials and Methods

1. Patient selection and planning

Nine patients with pancreatic tumors treated for stereotactic MRgRT at Seoul National University Hospital were retrospectively registered after obtaining Institutional Review Board of the Seoul National University Hospital approval (IRB No. 1708-051-876). Informed consent was not required in this study because only image data were used and they presented minimal risk of harm to subjects. The patients initially had a CT and MR simulation. During the CT simulation step, the patients were positioned with MR dummy coils placed on the abdomen to imitate the MR simulation. The planning CT image acquisition was conducted with the Brilliance CT Big Bore (Philips, Amsterdam, Netherlands) scanner with 120 kVp, 2 mm slice thickness, and YA reconstruction kernel with iDose 4 level. Simulation MR images were obtained with the MRIdian (ViewRay Inc, Mountain View, CA, USA) Cobalt-60 system using the identical patient position and immobilization devices like the CT simulation.
The primary images for contouring targets and organs at risk (OARs) were chosen with simulation MR images while the CT images were deformable and registered to the primary images for defining ED. The gross tumor volume (GTV) was delineated using both CT and MR images, and the planning target volume (PTV) was established as a 4 mm expansion from the GTV. The prescription dose of 45–50 Gy, with a daily dose of 9–10 Gy, was delivered to the PTV using a 5-fraction regimen. The plan optimization and dose calculation were computed using the MRIdian system with a 0.35 T magnetic field condition. The plan was normalized to cover 95% of the PTV with 100% of the prescribed dose.

2. Electron density modification

We generated the additional dose distributions utilizing identical beam parameters except for the ED map. The first dose distribution was evaluated using CT-derived ED. It is known as “Original.” The second dose distribution is known as “bulk density assign, BDA.” The air cavities in both CT and MR images were segmented and manually adapted using image threshold. The air cavities in the CT images were virtually filled with water ED, whereas the cavities in the MR images were assigned to air ED. The third dose distribution was calculated using synthetic CT-driven ED, known as “sCT.” The synthetic CT images were created using a deep learning model trained with the CycleGAN architecture from simulation MR images. The structural framework of the deep learning network and training procedures were discussed in the previous study [12]. To modify the ED map, we modified the simulation CT images to synthetic CT images. Fig. 1 depicts the overall procedure of the study.

3. Dosimetry evaluation

We contrasted the dose-volumetric parameters of each plan to determine the effect of air cavity variation on planning. For target volume, the following parameters were calculated: near dose maximum (D5%) near dose minimum (D95%), and dose maximum. The target volume’s homogeneity index (HI) and conformity index were also computed, with the definitions as follows:
(1)
HI= D5D95Dp
where D5 and D95 are the minimum doses in 5% and 95% of the target volume, respectively, and Dp is the prescribed dose [14]. The ideal value is zero when D5 and D95 are equal.
(2)
Conformity index= VRITV
where VRI is the volume of the reference isodose and TV is the target volume [15].
Dose-volume histograms (DVHs) were estimated for the OARs and clinically significant parameters were extracted. The DVH parameters were statistically analyzed using the paired t-test and IBM SPSS Statistics v25 software (IBM Corporation, Armonk, NY, USA). Statistical significance was defined as P-values less than 0.05.
We also evaluated the DVH parameter difference on the residual values between the plans using an outlier detection algorithm. A Z-score method depends on the mean and standard deviation of the data to calculate central tendency. However, the drawback of the Z-score approach prevalently never detects an outlier if the dataset contains fewer than 12 samples. A modified Z-score approach was created to quantify in small-size datasets or data that is not typically distributed using median absolute deviation and median values rather than mean and standard deviation [16]. We used the modified Z-score method with threshold 2 to symbolize the DVH parameter discrepancy cases.
Finally, we conducted a 3D gamma analysis to create a map denoting the location of the points with a large dose difference using the PyMedPhys library (https://docs.pymedphys.com/). The gamma criteria of 1%/1 mm and 2%/2 mm with a 10% threshold were used.

Results

Fig. 2 depicts an example of a simulation MR (left), simulation CT (middle), and synthetic CT (right) slices from the OAR location. The red circles indicate a difference in the locations of air cavities between the simulation CT and MR images. However, the air region patterns were similar in the synthetic CT generated from the MR images.
Table 1 shows dose-histogram parameters that describe PTV dose coverage for the three plans. D95% averages were 48.80 Gy, 48.50 Gy, and 48.23 Gy for Original, BDA, and sCT dose distributions, respectively. The greatest deviation was observed in one patient, whose D95% to sCT was 1.84 Gy higher than in the Original plan. The average dose differences of Dmax to the Original plan according to ED modification were discovered to be less than 0.69 Gy. However, the DVH parameters before and after ED modifications were not observed to be statistically significant except for the HI.
Table 2 summarizes the dosimetric results of the ED modification for OARs. For the liver, the V25Gy values were 11.74 and 11.72 cc for BDA and sCT methods, respectively. There were no statistically significant differences in the dosimetric parameters between the Original and the two ED modifications.
Table 3 displays the modified Z-score results for each case based on the dosimetric differences from the Original. We boldly highlighted the outlier cases that exceed the threshold value (2.0). For case #4, two dosimetric parameters (D98% and D95%) are considered outliers at both BDA and sCT dose maps compared with the Original. Fig. 3a displays the DVH of the outlier case in the target volume. DVH curves are illustrated in Fig. 3b by selecting a case with a lower modified Z-score value for visual comparison.
Table 4 shows the average gamma analysis results for three dose distributions. Overall, for BDA and sCT, gamma analysis pass rates at 1%/1 mm between Original and ED modification plans were 96.86% and 96.38%, respectively. The lowest gamma analysis result at 1%/1 mm between Original and sCT plans was 92.22%, which increased to 97.84% when two ED modification methods were compared. For the remaining patients, the passing rates between BDA and sCT were also slightly higher (98.91%) than the Original plan. Generally, gamma analysis at 2%/2 mm was insufficiently sensitive to represent ED modifications (pass rates ranging from 98.90% to 99.99%).

Discussion

Because of its superior soft tissue contrast, the onboard MR imager improves the visibility of the tumor volume and related OARs during treatment. By providing volumetric MR images, these characteristics enable online adaptive radiotherapy for interfraction modification and intrafraction motion management [17]. Image alignment between simulation and daily MR images, followed by couch positioning, could enhance patient positioning. If the couch positioning is not compensating for OAR variation, reidentification of the target and OARs contours would be conducted and the dose distribution would be reoptimized. However, one major impediment to these processes in adaptive radiotherapy is the extensive workload required for contour editing and delineation [2]. Particularly, because the position of the air pockets is randomly distributed, it is critical to manually define the contour in each treatment [18]. Therefore, we retrospectively evaluated the dosimetric effects on modified ED maps that were either manually assigned to the air cavity region or altered by synthetic CT images generated with a simple endeavor.
Despite the lack of statistically significant differences in the dosimetric parameters between the Original and ED override plans, modifications in the air cavity positions during simulation or treatment cause dose differences in some cases. For example, the parameters are substantially impacted when the cavity region varies around the target volume. Those, on the other hand, have less influence because the changing position is further away from the region of interest. We addressed these cases using the modified Z-score approach to uncover the dosimetric parameter discrepancy from the Original. Fig. 4 depicts a case, designated as an outlier by the algorithm, in which the cavity locations differed between CT and MR simulation. In the synthetic CT image, it was validated that the position of the air was comparable to that of the MR. For this case, reassigning the air cavity regions or changing the synthetic CT images to modify the ED should be conducted to evaluate the dose evaluation correctly.
The MRgRT process with online adaptation could enhance treatment outcomes while reducing OAR toxicity. Michalet et al. reported the dosimetric advantage of MRgRT for pancreatic cancers [19]. The daily adaptation indicated the benefit in terms of tumor coverage and OAR savings. An important step in the online adaptive workflow is the redelineation of the target, OARs even air cavities. To lower this labor-intensive step, only a region enclosing the target volume by 2 cm [20] or 3 cm [21] is typically assessed for contour adaptation. This approach, however, may result in an inaccurate assessment of the dosimetric parameters for OARs located far from the target.
Recently, deep learning-based image generation demonstrated exceptional performance in the medical imaging field. The deep learning-based model’s major benefit is that it can directly convert MR images into synthetic CT images within seconds. With a large dataset, the model learned the complex nonlinear relationship between two modality images and generated the corresponding CT HU values from the MR image in near real-time. This technique eliminates dose calculation errors caused by image registration between planning CT and MR images. This could reduce the uncertainty caused by changes in organ location, particularly the unpredictable air cavities between simulation and treatment time. Our study demonstrates the dosimetric similarity with gamma evaluation between the ED modification by manually assigning the regions and the automatically generated synthetic CT images. Though this sCT technique has the potential to overcome the limitations, clinical implementation will be hampered by the integration of the sCT algorithm into the treatment machine.
The small number of datasets used for the dosimetric evaluation is one of the study’s limitations. The sample size was insufficient to generate a statistically significant difference between the original dose distribution and the two modified dose distributions for ED map modifications. However, we proposed an outlier detection strategy to determine which cases were significantly affected by the air cavity changes. Second, we compared the two ED modification methods using the simulation CT and MR images. These images were obtained at roughly one-hour intervals, which may have had less of an impact on the variability of the organ position. Dosimetric parameters such as air cavity variation may have a greater impact on daily adaptation planning. In the future, a comparative analysis will be performed using the adaptive plans and daily MR images.

Conclusions

The variation of the air cavity position in the gastrointestinal area affects the daily treatment dose calculation. Synthetic CT-based ED modification would be a significant option for shortening the time-consuming process and improving MRgRT treatment accuracy.

Acknowledgements

This study was supported by a grant from the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2022R1F1A1063779).

Notes

Conflicts of Interest

The authors have nothing to disclose.

Availability of Data and Materials

All relevant data are within the paper and its Supporting Information files.

Author Contributions

Conceptualization: Hyeongmin Jin and Jung-in Kim. Data curation: Hyun Joon An. Formal analysis: Hyeongmin Jin and Hyun Joon An. Funding acquisition: Eui Kyu Chie and Jong Min Park. Investigation: Hyeongmin Jin. Methodology: Hyeongmin Jin and Hyun Joon An. Project administration: Jung-in Kim and Jong Min Park. Resources: Eui Kyu Chie and Jung-in Kim. Software: Hyeongmin Jin. Supervision: Eui Kye Chie and Jung-in Kim. Validation: Hyeongmin Jin. Visualization: Hyeongmin Jin. Writing – original draft: Hyeongmin Jin. Writing – review & editing: Jung-in Kim.

References

1. Lim-Reinders S, Keller BM, Al-Ward S, Sahgal A, Kim A. 2017; Online adaptive radiation therapy. Int J Radiat Oncol Biol Phys. 99:994–1003. DOI: 10.1016/j.ijrobp.2017.04.023. PMID: 28916139.
crossref
2. Kurz C, Buizza G, Landry G, Kamp F, Rabe M, Paganelli C, et al. 2020; Medical physics challenges in clinical MR-guided radiotherapy. Radiat Oncol. 15:93. DOI: 10.1186/s13014-020-01524-4. PMID: 32370788. PMCID: PMC7201982.
crossref
3. Hassanzadeh C, Rudra S, Bommireddy A, Hawkins WG, Wang-Gillam A, Fields RC, et al. 2020; Ablative five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online MR-guided adaptation. Adv Radiat Oncol. 6:100506. DOI: 10.1016/j.adro.2020.06.010. PMID: 33665480. PMCID: PMC7897757.
crossref
4. Intven MPW, de Mol van Otterloo SR, Mook S, Doornaert PAH, de Groot-van Breugel EN, Sikkes GG, et al. 2021; Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience. Radiother Oncol. 154:172–178. DOI: 10.1016/j.radonc.2020.09.024. PMID: 32976875.
crossref
5. Kupelian P, Sonke JJ. 2014; Magnetic resonance-guided adaptive radiotherapy: a solution to the future. Semin Radiat Oncol. 24:227–232. DOI: 10.1016/j.semradonc.2014.02.013. PMID: 24931098.
crossref
6. Pollard JM, Wen Z, Sadagopan R, Wang J, Ibbott GS. 2017; The future of image-guided radiotherapy will be MR guided. Br J Radiol. 90:20160667. DOI: 10.1259/bjr.20160667. PMID: 28256898. PMCID: PMC5605101.
crossref
7. Mutic S, Dempsey JF. 2014; The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol. 24:196–199. DOI: 10.1016/j.semradonc.2014.02.008. PMID: 24931092.
crossref
8. Maspero M, Savenije MHF, Dinkla AM, Seevinck PR, Intven MPW, Jurgenliemk-Schulz IM, et al. 2018; Dose evaluation of fast synthetic-CT generation using a generative adversarial network for general pelvis MR-only radiotherapy. Phys Med Biol. 63:185001. DOI: 10.1088/1361-6560/aada6d. PMID: 30109989.
crossref
9. Spadea MF, Pileggi G, Zaffino P, Salome P, Catana C, Izquierdo-Garcia D, et al. 2019; Deep convolution neural network (DCNN) multiplane approach to synthetic CT generation From MR images-application in brain proton therapy. Int J Radiat Oncol Biol Phys. 105:495–503. DOI: 10.1016/j.ijrobp.2019.06.2535. PMID: 31271823.
crossref
10. Maspero M, Bentvelzen LG, Savenije MHF, Guerreiro F, Seravalli E, Janssens GO, et al. 2020; Deep learning-based synthetic CT generation for paediatric brain MR-only photon and proton radiotherapy. Radiother Oncol. 153:197–204. DOI: 10.1016/j.radonc.2020.09.029. PMID: 32976877.
crossref
11. Qi M, Li Y, Wu A, Jia Q, Li B, Sun W, et al. 2020; Multi-sequence MR image-based synthetic CT generation using a generative adversarial network for head and neck MRI-only radiotherapy. Med Phys. 47:1880–1894. DOI: 10.1002/mp.14075. PMID: 32027027.
crossref
12. Kang SK, An HJ, Jin H, Kim JI, Chie EK, Park JM, et al. 2021; Synthetic CT generation from weakly paired MR images using cycle-consistent GAN for MR-guided radiotherapy. Biomed Eng Lett. 11:263–271. DOI: 10.1007/s13534-021-00195-8. PMID: 34350052. PMCID: PMC8316520.
crossref
13. Boulanger M, Nunes JC, Chourak H, Largent A, Tahri S, Acosta O, et al. 2021; Deep learning methods to generate synthetic CT from MRI in radiotherapy: a literature review. Phys Med. 89:265–281. DOI: 10.1016/j.ejmp.2021.07.027. PMID: 34474325.
crossref
14. Kataria T, Sharma K, Subramani V, Karrthick KP, Bisht SS. 2012; Homogeneity Index: an objective tool for assessment of conformal radiation treatments. J Med Phys. 37:207–213. DOI: 10.4103/0971-6203.103606. PMID: 23293452. PMCID: PMC3532749.
crossref
15. Feuvret L, Noël G, Mazeron JJ, Bey P. 2006; Conformity index: a review. Int J Radiat Oncol Biol Phys. 64:333–342. DOI: 10.1016/j.ijrobp.2005.09.028. PMID: 16414369.
crossref
16. Iglewicz B, Hoaglin DC. 1993. How to detect and handle outliers. ASQC Quality Press;Milwaukee:
17. Boldrini L, Cusumano D, Cellini F, Azario L, Mattiucci GC, Valentini V. 2019; Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. Radiat Oncol. 14:71. DOI: 10.1186/s13014-019-1275-3. PMID: 31036034. PMCID: PMC6489212.
crossref
18. Jin H, Kim DY, Park JM, Kang HC, Chie EK, An HJ. 2019; Dosimetric effects of air pocket during magnetic resonance-guided adaptive radiation therapy for pancreatic cancer. Prog Med Phys. 30:104–111. DOI: 10.14316/pmp.2019.30.4.104.
crossref
19. Michalet M, Bordeau K, Cantaloube M, Valdenaire S, Debuire P, Simeon S, et al. 2022; Stereotactic MR-guided radiotherapy for pancreatic tumors: dosimetric benefit of adaptation and first clinical results in a prospective registry study. Front Oncol. 12:842402. DOI: 10.3389/fonc.2022.842402. PMID: 35356227. PMCID: PMC8959839.
crossref
20. Werensteijn-Honingh AM, Kroon PS, Winkel D, Aalbers EM, van Asselen B, Bol GH, et al. 2019; Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: multi-fraction treatment of pelvic lymph node oligometastases. Radiother Oncol. 134:50–54. DOI: 10.1016/j.radonc.2019.01.024. PMID: 31005224.
crossref
21. Bohoudi O, Bruynzeel AME, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ, et al. 2017; Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Radiother Oncol. 125:439–444. DOI: 10.1016/j.radonc.2017.07.028. PMID: 28811038.
crossref

Fig. 1
Schematic diagram of the overall procedure. CT, computed tomography; MR, magnetic resonance.
pmp-33-4-142-f1.tif
Fig. 2
Example of simulation MR (left) and CT (center) images with air cavities located near the organ at risk. The synthetic CT image generated from the simulation MR is displayed at the right. MR, magnetic resonance; CT, computed tomography.
pmp-33-4-142-f2.tif
Fig. 3
Dose-volume histograms of representative cases: case surpassing the threshold of the modified Z-score (a), and relatively lower score case (b). The solid, dash and dot lines represent the Original, bulk density assign, and sCT dose distributions, respectively. PTV, planning target volume; sCT, synthetic computed tomography-driven electron density.
pmp-33-4-142-f3.tif
Fig. 4
Example of simulation MR (left) and CT (center) slices with air cavities located near the target volume. The synthetic CT image generated from the simulation MR is displayed at the right. MRI, magnetic resonance; CT, computed tomography.
pmp-33-4-142-f4.tif
Table 1
Comparison of dose-volumetric parameters for target volume according to Original, BDA, and sCT dose distributions
Dose-volumetric parameter Original BDA sCT
D98% (Gy) 47.62±2.32 47.31±2.30 47.00±2.38
D95% (Gy) 48.80±2.08 48.50±2.13 48.23±2.25
Dmax (Gy) 58.31±4.99 58.41±5.26 57.92±5.47
Homogeneity index 0.16±0.08 0.17±0.08* 0.17±0.08*
Conformity index 0.97±0.01 0.95±0.03 0.93±0.06
Table 2
Comparison of dose-volumetric parameters for OARs according to Original, BDA, and sCT dose distributions
Dose-volumetric parameter Original BDA sCT
Stomach V36Gy (cc) 0.02±0.04 0.03±0.04 0.03±0.05
Duodenum V36Gy (cc) 0.16±0.24 0.15±0.21 0.13±0.20
Liver V25Gy (cc) 11.73±16.83 11.74±16.81 11.72±16.72
Liver Dmean (Gy) 2.90±2.20 2.90±2.19 2.89±2.18
Spinal Cord V25Gy (cc) 0.00±0.00 0.00±0.00 0.00±0.00
Table 3
Modified Z-scores for the selected dosimetric parameters of the target volume in terms of electron density modification methods for nine patients
Case number Original-BDA Original-sCT



D98% D95% Dmax D98% D95% Dmax
Case #1 0.05 0.09 −0.85 −0.26 −0.14 −0.39
Case #2 0.38 −0.11 −0.40 0.22 0.02 0.06
Case #3 −0.92 −0.94 0.31 −0.10 −0.50 −1.16
Case #4 4.48 3.60 0.67 2.32 2.18 1.49
Case #5 0.00 0.00 −2.63 0.33 0.13 −0.13
Case #6 1.32 1.30 1.37 1.62 1.81 2.91
Case #7 1.11 1.42 0.59 1.12 1.09 1.21
Case #8 0.32 0.16 −0.73 0.67 0.67 0.37
Case #9 0.67 0.67 0.02 0.83 0.85 0.67
Table 4
Gamma analysis pass-rate results for comparison between dose distributions from Original, BDA, and sCT
Statistics Original, BDA Original, sCT BDA, sCT





2%/2 mm 1%/1 mm 2%/2 mm 1%/1 mm 2%/2 mm 1%/1 mm
Mean (%) 99.62±0.21 96.86±0.71 99.68±0.34 96.38±1.83 99.74±0.21 98.91±0.50
Min (%) 99.20 95.72 98.90 92.22 99.36 97.84
TOOLS
Similar articles